Precigen Inc (PGEN) - Net Assets

Latest as of December 2025: $20.91 Million USD

Based on the latest financial reports, Precigen Inc (PGEN) has net assets worth $20.91 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($156.62 Million) and total liabilities ($135.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore PGEN cash flow conversion to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric	Value
Current Net Assets	$20.91 Million
% of Total Assets	13.35%
Annual Growth Rate	N/A
5-Year Change	-80.52%
10-Year Change	-96.33%
Growth Volatility	43.67

Precigen Inc - Net Assets Trend (2011–2025)

This chart illustrates how Precigen Inc's net assets have evolved over time, based on quarterly financial data. Explore Precigen Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Annual Net Assets for Precigen Inc (2011–2025)

The table below shows the annual net assets of Precigen Inc from 2011 to 2025. For live valuation and market cap data, see market value of Precigen Inc.

Year	Net Assets	Change
2025-12-31	$20.91 Million	-45.70%
2024-12-31	$38.51 Million	-67.50%
2023-12-31	$118.50 Million	-6.15%
2022-12-31	$126.26 Million	+17.62%
2021-12-31	$107.35 Million	+59.81%
2020-12-31	$67.17 Million	-6.33%
2019-12-31	$71.71 Million	-81.07%
2018-12-31	$378.72 Million	-30.71%
2017-12-31	$546.54 Million	-3.99%
2016-12-31	$569.25 Million	-19.24%
2015-12-31	$704.89 Million	+72.22%
2014-12-31	$409.29 Million	+7.33%
2013-12-31	$381.34 Million	+218.59%
2012-12-31	$-321.55 Million	-45.33%
2011-12-31	$-221.26 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Precigen Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 212008900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Comprehensive Income	$7.00K	0.03%
Other Components	$2.36 Billion	11296.70%
Total Equity	$20.91 Million	100.00%

Precigen Inc Competitors by Market Cap

The table below lists competitors of Precigen Inc ranked by their market capitalization.

Company	Market Cap
China Sports Industry Group Co Ltd SHG:600158	$1.50 Billion
Zhejiang Jiecang Linear Motion Technology Co Ltd SHG:603583	$1.50 Billion
ConnectOne Bancorp, Inc. NASDAQ:CNOB	$1.50 Billion
Sunwave Communications Co Ltd SHE:002115	$1.50 Billion
Gree Real Estate Co Ltd SHG:600185	$1.50 Billion
Chinese Universe Publishing And Media Co Ltd SHG:600373	$1.50 Billion
Shanghai Qiangsheng Holding Co Ltd SHG:600662	$1.50 Billion
Peker Gayrimenkul Yatirim Ortakligi AS IS:PEKGY	$1.50 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Precigen Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 38,513,000 to 20,911,000, a change of -17,602,000 (-45.7%).
Net loss of 250,642,000 reduced equity.
Share repurchases of 2,196,000 reduced equity.
Other comprehensive income decreased equity by 5,000.
Other factors increased equity by 235,241,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	$-250.64 Million	-1198.61%
Share Repurchases	$2.20 Million	-10.5%
Other Comprehensive Income	$-5.00K	-0.02%
Other Changes	$235.24 Million	+1124.96%
Total Change	$-	-45.70%

Book Value vs Market Value Analysis

This analysis compares Precigen Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 64.12x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2011-12-31	$-39.06	$4.40	x
2012-12-31	$-58.11	$4.40	x
2013-12-31	$8.95	$4.40	x
2014-12-31	$3.88	$4.40	x
2015-12-31	$6.25	$4.40	x
2016-12-31	$4.75	$4.40	x
2017-12-31	$4.45	$4.40	x
2018-12-31	$2.80	$4.40	x
2019-12-31	$0.47	$4.40	x
2020-12-31	$0.40	$4.40	x
2021-12-31	$0.54	$4.40	x
2022-12-31	$0.63	$4.40	x
2023-12-31	$0.48	$4.40	x
2024-12-31	$0.14	$4.40	x
2025-12-31	$0.07	$4.40	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Precigen Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -1198.61%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -2588.21%
• Asset Turnover: 0.06x
• Equity Multiplier: 7.49x
Recent ROE (-1198.61%) is below the historical average (-160.14%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	0.00%	-1064.27%	0.07x	0.00x	$-63.15 Million
2012	0.00%	-587.96%	0.09x	0.00x	$-49.72 Million
2013	-10.63%	-164.06%	0.05x	1.28x	$-75.65 Million
2014	-21.27%	-113.75%	0.12x	1.50x	$-120.30 Million
2015	-12.17%	-48.67%	0.18x	1.41x	$-153.90 Million
2016	-33.31%	-97.74%	0.20x	1.69x	$-242.64 Million
2017	-21.93%	-50.66%	0.27x	1.59x	$-170.38 Million
2018	-140.37%	-317.20%	0.22x	1.97x	$-545.62 Million
2019	-237.79%	-533.01%	0.07x	6.36x	$-177.69 Million
2020	-253.85%	-533.01%	0.10x	4.68x	$-177.24 Million
2021	-85.86%	-646.01%	0.04x	3.35x	$-102.90 Million
2022	22.43%	105.23%	0.12x	1.71x	$15.69 Million
2023	-80.93%	-1540.63%	0.04x	1.27x	$-107.75 Million
2024	-327.77%	-3216.18%	0.03x	3.77x	$-130.09 Million
2025	-1198.61%	-2588.21%	0.06x	7.49x	$-252.73 Million

Industry Comparison

This section compares Precigen Inc's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $60,677,567
Average return on equity (ROE) among peers: -58.27%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Precigen Inc (PGEN)	$20.91 Million	0.00%	6.49x	$1.50 Billion
Aardvark Therapeutics, Inc. Common Stock (AARD)	$-34.80 Million	0.00%	0.00x	$86.88 Million
Abcellera Biologics Inc (ABCL)	$10.25 Million	-21.57%	1.29x	$1.60 Billion
Abeona Therapeutics Inc (ABEO)	$42.37 Million	-200.47%	0.88x	$323.66 Million
Acumen Pharmaceuticals Inc (ABOS)	$225.18 Million	-44.68%	0.02x	$183.46 Million
Abpro Holdings, Inc. (ABP)	$-22.46 Million	0.00%	0.00x	$2.00 Million
Absci Corp (ABSI)	$179.13 Million	-57.56%	0.19x	$804.47 Million
Arbutus Biopharma Corp (ABUS)	$203.00 Million	-189.21%	0.36x	$854.72 Million
ABVC Biopharma Inc (ABVC)	$60.67K	-43.96%	0.04x	$27.18 Million
Abivax SA American Depositary Shares (ABVX)	$56.72 Million	-25.23%	0.07x	$9.73 Billion
ACADIA Pharmaceuticals Inc (ACAD)	$-52.67 Million	0.00%	0.00x	$3.63 Billion

About Precigen Inc

NASDAQ:PGEN USA Biotechnology

Market Cap

$1.57 Billion

Market Cap Rank

#7410 Global

#2155 in USA

Share Price

$4.40

Change (1 day)

+3.77%

52-Week Range

$1.32 - $5.21

All Time High

$42.80